These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31274409)

  • 21. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.
    Griekspoor A; Sondorp E; Vos T
    Health Policy Plan; 1999 Mar; 14(1):70-6. PubMed ID: 10351471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs.
    Lim SS; Gaziano TA; Gakidou E; Reddy KS; Farzadfar F; Lozano R; Rodgers A
    Lancet; 2007 Dec; 370(9604):2054-62. PubMed ID: 18063025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women.
    Finkelstein EA; Khavjou O; Will JC
    J Womens Health (Larchmt); 2006 May; 15(4):379-89. PubMed ID: 16724886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of Social Determinants of Health Interventions: Evaluating Multisector Community Partnerships' Efforts.
    Honeycutt AA; Khavjou OA; Tayebali Z; Dempsey M; Glasgow L; Hacker K
    Am J Prev Med; 2024 Jul; ():. PubMed ID: 39053657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
    Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
    PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
    Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
    Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
    Lo NC; Bogoch II; Blackburn BG; Raso G; N'Goran EK; Coulibaly JT; Becker SL; Abrams HB; Utzinger J; Andrews JR
    Lancet Glob Health; 2015 Oct; 3(10):e629-38. PubMed ID: 26385302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Prevention Impacts Simulation Model to Estimate Long-Term Impacts of Multisector Community Partnerships' Efforts to Address Social Determinants of Health.
    Honeycutt AA; Yarnoff B; Tayebali Z; Glasgow L; Hacker K
    Prev Chronic Dis; 2023 Jul; 20():E62. PubMed ID: 37471635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity a community guide systematic review.
    Nurmagambetov TA; Barnett SB; Jacob V; Chattopadhyay SK; Hopkins DP; Crocker DD; Dumitru GG; Kinyota S;
    Am J Prev Med; 2011 Aug; 41(2 Suppl 1):S33-47. PubMed ID: 21767734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Realistic outcomes: lessons from community-based research and demonstration programs for the prevention of cardiovascular diseases.
    Mittelmark MB; Hunt MK; Heath GW; Schmid TL
    J Public Health Policy; 1993; 14(4):437-62. PubMed ID: 8163634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
    Hendriks ME; Bolarinwa OA; Nelissen HE; Boers AC; Gomez GB; Tan SS; Redekop W; Adenusi P; Lange JM; Agbede K; Akande TM; Schultsz C
    J Hypertens; 2015 Feb; 33(2):376-684. PubMed ID: 25380164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost and cost-effectiveness analysis of a community mobilisation intervention to reduce intimate partner violence in Kampala, Uganda.
    Michaels-Igbokwe C; Abramsky T; Devries K; Michau L; Musuya T; Watts C
    BMC Public Health; 2016 Feb; 16():196. PubMed ID: 26924488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost-effectiveness of forty health interventions in Guinea.
    Jha P; Bangoura O; Ranson K
    Health Policy Plan; 1998 Sep; 13(3):249-62. PubMed ID: 10187595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis.
    Holtgrave DR
    AIDS; 2002 Nov; 16(17):2347-9. PubMed ID: 12441812
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.